AGREE II Quality Assessment of National and International Clinical Practice Guidelines on Prostate Cancer Management by the OPTIMA Consortium

Sakalis Vasileios² , Bhattacharya Yagnaseni³ , Beyer Katharina⁴ , Murray Charlotte⁵ , Smith E.J.⁶ , Willemse P.M. ^{7, 8} , Gandaglia Giorgio⁹ , Boissier Romain¹⁰ , Borkowetz Angelika¹¹ , Dabestani Saeed^{12, 13} , Leenen R.C.⁴ , Vilaseca Antoni¹⁴ , Maresca Gianluca¹⁵ , Teoh Jeremy¹⁶ , Gómez Rivas Juan¹⁷ , Rajwa Pawel ^{18, 19} , Lardas Michael²⁰ , Grivas Nikolas²¹ , Van den Broeck Thomas²² , Pradere Benjamin ²³ , Schouten Natasha⁶ , Tandogdu Zafer²⁴ , Evans-Axelsson Susan²⁵ , Maclennan Steven⁵ , Thomas Marlene²⁶ , Briganti Alberto⁹ , Bjartell Anders²⁷ , Cornford Phil²⁸ , Kruger Hagen , N’Dow James⁵ , Roobol M.J. ⁴ , Omar M.I.⁵

European Urology Open Science

Elsevier B.V.

English

183-193

Published

70

2024

• ¹ Hippokrateion General Hospital of Thessaloniki, Urology, Thessaloniki, Greece;
• ² Division of Medical and Dental Education, Aberdeen Medical School, Aberdeen, UK;
• ³ Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands;
• ⁴ Academic Urology Unit, University of Aberdeen, Aberdeen, Scotland, UK;
• ⁵ European Association of Urology Guidelines Office, Arnhem, The Netherlands;
• ⁶ Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands;
• ⁷ Department of Urology,
• ⁸ Department of Urology and Division of Experimental Oncology, Urological Research Institute, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy;
• ⁹ Department of Urology and Renal transplantation, APHM, Aix-Marseille Université, Marseille, France;
• ¹⁰ Department of Urology, Technische Universität Dresden, Dresden, Germany;
• ¹¹ Department of Translational Medicine, Section Division of Urological Cancers, Lund University, Lund, Sweden;
• ¹² Department of Urology, Kristianstad Central Hospital, Region Skane, Kristianstad, Sweden;
• ¹³ Servicio de Urología, Hospital Clínic de Barcelona, Barcelona, Spain;
• ¹⁴ Department of Urology, Aberdeen Royal Infirmary, Aberdeen, Scotland, UK;
• ¹⁵ S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China;
• ¹⁶ Department of Urology, Hospital Clinico San Carlos, Madrid, Spain;
• ¹⁷ Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria;
• ¹⁸ Department of Urology, Medical University of Silesia, Zabrze, Poland;
• ¹⁹ Department of Urology, Metropolitan General Hospital, Athens, Greece;
• ²⁰ Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands;
• ²¹ Department of Urology, University Hospitals Leuven, Leuven, Belgium;
• ²² Department of Urology, La Croix Du Sud Hospital, Quint Fonsegrives, France;
• ²³ Department of Urology, University College London Hospitals, London, UK;
• ²⁴ Bayer AG, Berlin, Germany;
• ²⁵ Roche, Basel, Switzerland;
• ²⁶ Department of Translational Medicine, Lund University, Lund, Sweden;
• ²⁷ Department of Urology, Liverpool University Hospitals Foundation Trust, Liverpool, UK;
• ²⁸ Medical Affairs, Pfizer, Berlin, Germany